International Journal of Phytomedicine and Phytotherapy
Treatment groups | Glucose (mg/dL) | Albumin (g/dL) | ALP (U/L) | ALT (U/L) | AST (U/L) | Creat (g/dL) | Protein (mg/dL) | Urea (mg/dL) |
---|---|---|---|---|---|---|---|---|
Normal Control | 92.8 ± 5.5b | 2.25 ± 20.5a | 265.9 ± 5.3c | 46.1 ± 28.4b | 189.7 ± 0.3b | 0.2 ± 0.1 | 9.4 ± 2.5a | 38.1 ± 0.0b |
Diabetic Control | 374.2 ± 57.5a | 1.6 ± 43.5b | 735.1 ± 7.6a | 84.4 ± 70.5a | 316.7 ± 0.4a | 0.25 ± 0.1 | 6.7 ± 2.3b | 62.7 ± 0.0a |
CTE I | 314.5 ± 81.9a | 1.9 ± 24.8ab | 563.3 ± 11.3ab | 67.8 ± 88.9ab | 202.7 ± 0.3b | 0.24 ± 0.1 | 7.2 ± 3.7b | 56.5 ± 0.0a |
CTE II | 225.2 ± 69.5ab | 1.8 ± 28.3b | 448.0 ± 7.8bc | 47.5 ± 72.4b | 205.2 ± 0.6ab | 0.25 ± 0.1 | 7.0 ± 5.2b | 50.0 ± 0.0ab |
Glibenclamide positive control | 187.4 ± 14.2ab | 1.9 ± 20.0ab | 487.9 ± 4.6abc | 38.5 ± 86.8b | 173.5 ± 0.6b | 0.23 ± 0.1 | 7.9 ± 5.4ab | 53.4 ± 0.0ab |